EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-SA 4.0

Role of Micro RNA Expression as Biomarker in Breast Cancer

Gitika Nanda Singh, Nijarth Shahi, Parijat Suryavanshi, Krishna Kant Singh, Neetu Nigam

Annals of African Medicine · 2025-07 · 24 (3) · 549-554

DOI: 10.4103/aam.aam_78_23 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of African Medicine, online erschienen am 24.07.2025. Verfasst von Gitika Nanda Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, King George's Medical University, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The most common cancer in women is breast cancer (BC). MicroRNA-21 was one of the first oncomiRs to be found at elevated levels in a number of malignancies, including gliomas, BC, and colorectal cancer (miR-21). MiRNA is associated with processes such as apoptosis, invasion, metastasis, and proliferation, which are known features of cancer. This study aimed to investigate the molecular basis and clinical significance of miR-21 in BC, as microRNAs play a critical role in this disease. Materials and Methods: MiR 21 was then analyzed by the quantitative polymerase chain reaction (qPCR) using the Taq-Man probe. The thermal profile included 5 min of denaturation at 95°C, then 40 cycles of denaturation at 95°C for 20 s, annealing at 52°C for 20 s, and extension at 72°C for 30 s. Two separate runs of real-time polymerase chain reaction and reverse transcription (RT) were then performed. Relative quantification of the gene expression levels (fold change) based on computed tomography values was used to examine the data from RT-qPCR for miR-21 and Glyceraldehyde-3-phosphate dehydrogenase (Livak and Schmittgen).

Results

The mean fold change in serum miR-21 levels was significantly higher in cases (8.17 ± 2.49) than in controls (1.02 ± 0.23). The mean fold change in serum miR-21 levels in Stages III, IV and lymph nodes were significantly higher than in Stages I and II. The mean fold change in serum miR-21 gene expression was significant with the changes in different Ki67 levels.

Conclusions

Our results demonstrate the importance of miR-21 plasma level as a diagnostic and prognostic biomarker for BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsBiomarkers, TumorHumansFemaleMiddle AgedReal-Time Polymerase Chain ReactionAdultGene Expression Regulation, NeoplasticAged

Stichwörter der Autor:innen

Breast cancerCancer du seinKi67microARN-21microRNA-21quantitative polymerase chain reaction epithelial-to-mesenchymal transitiontransition épithéliale-mésenchymateuse quantitative par réaction en chaîne par…

Substanzen

MicroRNAsBiomarkers, TumorMIRN21 microRNA, human

Autor:innen und Institutionen

  • Department of General Surgery, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • CFAR Cytogenetics Lab, King George's Medical University, Lucknow, Uttar Pradesh, India.

Zitieren

APA

Singh, G. N., Shahi, N., Suryavanshi, P., Singh, K. K., & Nigam, N. (2025). Role of Micro RNA Expression as Biomarker in Breast Cancer. Annals of African Medicine, 24(3), 549-554. https://doi.org/10.4103/aam.aam_78_23

Vancouver

Singh GN, Shahi N, Suryavanshi P, Singh KK, Nigam N. Role of Micro RNA Expression as Biomarker in Breast Cancer. Annals of African Medicine. 2025;24(3):549-554. doi:10.4103/aam.aam_78_23

BibTeX
@article{Singh2025,
  author = {Singh, Gitika Nanda and Shahi, Nijarth and Suryavanshi, Parijat and Singh, Krishna Kant and Nigam, Neetu},
  title = {Role of Micro RNA Expression as Biomarker in Breast Cancer},
  journal = {Annals of African Medicine},
  year = {2025},
  volume = {24},
  number = {3},
  pages = {549--554},
  doi = {10.4103/aam.aam_78_23}
}
Kostenlos starten →